Veriheal

MAY 26, 2022

In turn, cannabis advocates have struggled to properly educate the public with the limited amount of scientific evidence available. Dedicated to “redefining what’s possible,” the 501(c)(3) organization has provided 1:1 support and resources to over 69,000 clients as they navigated plant-powered cannabinoid therapy.

Advocacy 98

Advocacy Patients Clinical Trials Education 98

Cannabis Law Report

FEBRUARY 28, 2022

Bronner’s, Partners with Pioneering Health Plan Administrator, Enthea, to Provide Psychedelic Therapy as Employee Healthcare Benefit. Leading US Company to Offer Employee Coverage for Ketamine Assisted Therapy to Promote Mental Health. First Ever Partnership Between Health Plan Administrator and.

Therapy 52

Therapy Treatment Research and Development Advocacy 52

Cannabis Law Report

AUGUST 18, 2022

The firm’s deep expertise in pharmaceutical sciences, FDA regulatory compliance and pharmaceutical product liability litigation and risk management enables it to address complex legal hurdles faced by stakeholders seeking to research, develop, invest in and bring-to-market psychedelic therapies. BUFFALO, N.Y. , Aug. Tweet this.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

StrainConnect

APRIL 23, 2019

Why Terpenes Are Vital To Your Cannabinoid Therapy. We feel like theres nothing better than an educated partaker. Newsletter Stay on top of the latest educational resources, app updates, CBD & cannabis news by signing up for our newsletter. Why Terpenes Are Vital To Your Cannabinoid Therapy. Dont worry.we Newsletter.

Terpenes 63

Terpenes Cannabinoids Therapy Sativa 63

The Joint Blog

NOVEMBER 4, 2019

The study found that 58% of physicians agree that “medical cannabis was a legitimate medical therapy.” ” However, as noted by NORML, around half of respondents “expressed discomfort in talking to their patients about medical cannabis options, a finding that is also consistent with prior data. Conclusions.

Therapy 42

Therapy Clinical Trials Conditions Patients 42

The Cannigma

NOVEMBER 11, 2021

Conducted in Spain, the study was a collaborative effort between researchers Jose’ Bouso, PhD from the International Center for Ethnobotanical Education, Research and Service, and Alberto Sainz-Cort, MSc from Universitat Oberta de Catalunya and GH Medical, among several other distinguished authors. CBD alters the subjective effects of THC.

CBD 141

CBD Research and Development THC Environment 141

Veriheal

JUNE 30, 2023

Researchers say this emphasizes just how important it is that psilocybin therapy be done in a controlled setting with therapy and community-based after-care. The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

The Cannigma

AUGUST 31, 2021

Medical societies are slowly providing more CME (continuing medical education) to doctors on cannabis, however, that educational content tends to be slanted toward risk mitigation. reported receiving no education about medical marijuana in medical school or residency. We have a ways to go,” Tan said.

Education 105

Education Clinical Trials Medicine Policy 105

LifeCannMD

MAY 27, 2025

” I completely understand this concern, and that’s exactly why I’m passionate about educating patients about microdosing cannabis. Sleep: What the Sleep Studies Reveal A groundbreaking 2020 study from the University of New Mexico analyzed sleep data from over 5,000 medical marijuana patients.

Microdosing 52

Microdosing Research and Development Sleep Chronic Pain 52

Cannabis Law Report

JANUARY 12, 2022

According to a recent report released by the Psychedelic Science Funders Collaborative, “Oregon’s psilocybin therapy program provides a high-quality model for psychedelic healing in a non-prescription context that could be replicated in other states.” ABOUT THE NATIONAL PSYCHEDELICS ASSOCIATION.

Research and Development 52

Research and Development Therapy Clinical Trials Safety 52

Cannabis Law Report

AUGUST 3, 2021

For CUNY, the Contract operationalizes the CDC’s ‘ Guidance for Institutions of Higher Education ’ aimed at disease control and minimizing the risk of exposure in education settings. Applied DNA is also the manufacturer of the EUA-authorized Linea™ COVID-19 Assay Kit.

Clinical Trials 81

Clinical Trials Therapy Collective Research and Development 81

Puff Puff Post

DECEMBER 28, 2018

We go deep into what this might mean for the future of therapy for Autism Spectrum Disorders (ASD), and how we might see the use of CBD oil for autism. An official study is aimed to conclude in July of 2019, where we’ll see all the data which comes forth. Success rates of up to 80% have been observed for CBD related autism therapy.

Treatment 76

Treatment Oil CBD Therapy 76

SpeedWeed

MAY 22, 2021

For this Phase 1 trial, MAPS will recruit 150 therapists that are currently being trained to conduct MDMA-assisted therapy sessions for PTSD. . This work builds capacity to deliver quality, accessible care to patients, pending approval of MDMA-assisted therapy as a legal prescription treatment.”.

Clinical Trials 52

Clinical Trials Therapy Legalization Research and Development 52

SpeedWeed

SEPTEMBER 17, 2021

million to assess the efficacy of Multidisciplinary Association for Psychedelic Studies (MAPS) MDMA-assisted therapy to treat traumatic brain injury (TBI). Wesana is a serious, thoughtful and ethical company engaged in the development of psychedelic-assisted therapy. Lately, MAPS research zeroed in on MDMA-assisted therapy for PTSD.

Clinical Trials 53

Clinical Trials Research and Development Therapy Treatment 53

Puff Puff Post

FEBRUARY 4, 2019

Physicians who treat young people now face a series of dilemmas: The anti-smoking therapies on the market — such as nicotine patches and gums — are not approved for children, due to lack of testing or ineffective results. with 1 in 4 high school students reportedly using the products, according to federal data.

Vaping 101

Vaping Therapy Programs Advocacy 101

The Cannigma

OCTOBER 21, 2021

Usually diagnosed in children, ADHD affects around 5% of children and 3% of adults worldwide and can cause challenges for sufferers’ education, work, and home life. Another study of 11,232 ADHD patients found that those patients who also had a cannabis use disorder used less medication and behavioural therapy. Adderall and cannabis.

Blood Pressure 137

Blood Pressure Treatment Patients Cannabis 137

Cannabis Law Report

AUGUST 23, 2021

There is no equivalent to dietary supplements in animals, because the Dietary Supplement and Health Education Act of 1994 does not apply to products meant for animal use. He added that significant data is still needed to inform policy regarding use of consumer cannabis products.

Pets 105

Pets Hemp CBD Food 105

Cannabis Law Report

APRIL 8, 2022

as a non-profit organization to fulfill the need to broaden psychedelic research, therapy, and develop legal options for psychedelic medicine. In MAPS’ 36th year, we’ll learn if our second Phase 3 study of MDMA-assisted therapy for PTSD was successful. The FDA received MAPS’ protocol for a new study of MDMA-assisted therapy for PTSD.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52

Cannabis Law Report

SEPTEMBER 2, 2021

Suffolk County Community College joins new safeCircle client The City University of New York, as well as several existing higher education institution clients, who have turned to us for COVID-19 testing to support their 2021-2022 academic year,” stated Dr. James A. Hayward, president and CEO of Applied DNA. “As

Clinical Trials 76

Clinical Trials Research and Development Therapy Collective 76

Cannabis Law Report

JULY 8, 2021

Instead, the punishments would include nothing at all, civil fines, drug education, and drug therapy. According to data from the National Survey on Drug Use and Health, 44 percent of men and 35 percent of women had smoked marijuana at some point in their lives. So yet, no state has legalised cannabis. percent or 16.7 million).

Legalization 75

Legalization Advocacy Legislation Cannabis 75

Cannabis Law Report

NOVEMBER 11, 2021

The City should produce educational public service announcements to inform the public about safety, responsible use, and available risk reduction services. The City should create a data collection reporting system for any interactions involving psilocybin for ongoing public safety monitoring. 2021-Comprehensive-Report.

Policy 52

Policy Decriminalization Safety Therapy 52

CannaMD

DECEMBER 9, 2020

The authors also list a range of additional conditions for which there are possible benefits of cannabis therapies, including opiate withdraw, dystonia, glaucoma, Alzheimer’s disease, anxiety and depression, anti-tumor effects, inflammatory bowel diseases, Parkinson’s disease, and sleep disorders. for men, 1.3%

Marijuana 111

Marijuana Research and Development Consumption Vaping 111

Veriheal

MARCH 3, 2022

Educational attainment. Since the study was dependent on self-reported data and contained scarce information pertaining to cannabis dosage, the authors noted that the question responses may have been somewhat limited. Duration of sleep was defined as follows: Short (less than 6 hours). Optimal (6-9 hours). Long (exceeding 9 hours).

Sleep 94

Sleep Consumption Cannabinoids Cannabis 94

Veriheal

NOVEMBER 13, 2020

The data of 87 individuals with OCD who tracked the severity of their intrusions, compulsions, and/or anxiety immediately before and after a total of 1810 cannabis use sessions over a time period of 31 months. . Cannabis can help OCD sufferers and is an all-natural form of therapy, which is gaining more and more support as time goes by. .

Research and Development 98

Research and Development Consumption Patients Strains 98

Cannabis Law Report

NOVEMBER 3, 2021

The Company continues to focus on medical training for healthcare professionals after receiving full Continuing Professional Development (“CPD”) accreditation for its digital educational platform, Khiron Academy, and brings its proprietary clinical data generated in LatAm to the UK.

Therapy 52

Therapy Access Patients Treatment 52

The Cannigma

MAY 16, 2025

and years of data proving the positive impacts that medical cannabis has on healthcare systems. Given his diverse pediatric pharmacy experience and knack for educating, he tries to share his knowledge whenever possible. ASA campaigns removed barriers for U.S. Codi Peterson is The Cannigma’s Chief Science Officer.

Policy 79

Policy Access Advocacy Patients 79

Miss Marijuana

JULY 30, 2019

About a year ago, data from the Strainprint app was used to analyze the impact of marijuana on depression, anxiety and stress. The data came from close to 12,000 entries (that’s a huge sample size!). Although to be transparent, the self-reported data also found extended uses of cannabis led to increased depression over time. .

Strains 12

Strains Data Cannabis THC 12

United Patients Group

AUGUST 16, 2023

Accessibility involves digital areas and data in addition to physical infrastructure. By providing assistive technology and fair accommodations for staff and students with disabilities or serious health conditions , employers and educational institutions may also embrace accessibility.

Advocacy 52

Advocacy Education Access Environment 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Research and Development 52

Research and Development Clinical Trials Therapy Pharmaceutical 52

CannaMD

MAY 14, 2020

Data from Colorado, which was among the first states to legalize marijuana, indicates that edible cannabis-infused products account for some 45% of all cannabis sales. These risks can be mitigated by a combination of consumer education, clear product labeling, and child-safe packaging methods. Why Do People Like Marijuana Edibles?

Edibles 105

Edibles Marijuana THC Vaping 105

Cannabis Law Report

SEPTEMBER 21, 2021

The longitudinal study, using data gathered from RoC’s Observational Research Registry (ORR), showed that individuals who initiated use of artisanal cannabidiol (CBD) products or continued use of CBD products at follow-up endorsed significant reductions in both anxiety and depression, improved sleep, and less pain compared with those not using CBD.

CBD 40

CBD Data Therapy Pharmaceutical 40

Cannabis Law Report

DECEMBER 2, 2021

Recommendations and rulemaking relating to training and products were placed on an expedited timeline to ensure that facilitators will be trained, and products will be ready for the January 2, 2023, launch of the first state-sponsored psilocybin therapy program in the United States. Training Administration Recommendations.

Law 52

Law Programs Therapy Education 52

Cannabis Law Report

NOVEMBER 19, 2021

MAPS PBC is pioneering a new form of mental health care, beginning with the development of MDMA-assisted therapy as an FDA-approved treatment for PTSD. MDMA-assisted therapy is a new paradigm in the treatment of mental health, combining a medicine with psychotherapy to address the root causes of PTSD.

Therapy 40

Therapy Compliance Compliance Clinical Trials 40

MMJ Recs

JUNE 15, 2022

There are many treatments that can be utilized along with MMJ products to alleviate pain, such as medications, physical therapy, and massage. Their website is a fount of information that indicates high patient satisfaction (including testimonials and data on clinical trials).

Patients 52

Patients Treatment Clinical Trials Therapy 52

Cannabis Law Report

JULY 28, 2021

The study was conducted by a respected contract research organization with deep expertise in preclinical oncology model development and drug testing and data corresponding to all studied cancer cell lines have now been reported to the Company.

Research and Development 105

Research and Development Clinical Trials Treatment Pharmaceutical 105

Cannabis Law Report

OCTOBER 12, 2021

safeCircle’s approach to COVID-19 testing, the combination of a comprehensive managed services offering and self-service reporting and communications platform provided by our partner, CLEARED4, continues to resonate with institutes of higher education seeking to keep populations safe and campuses open.

Programs 40

Programs Clinical Trials Research and Development Therapy 40

Cannabis Law Report

NOVEMBER 5, 2021

The proven platform has been utilized by numerous institutes of higher education, K-12 schools, businesses, and healthcare facilities with large populations. By providing both vaccine status management and weekly COVID-19 testing, the integrated platform offers a single solution for compliance with the ETS. Forward-Looking Statements.

Compliance 40

Compliance Compliance Research and Development Therapy 40